The effect of hormones on the lower urinary tract

Menopause International

Volumn 19, Issue 4, 2013, Pages 155-162

  Robinson, Dudley ^a   Toozs Hobson, Philip ^b   Cardozo, Linda ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Estrogen; overactive bladder; progesterone; stress urinary incontinence; urinary incontinence

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; OXYBUTYNIN; PROGESTERONE; TOLTERODINE; GESTAGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; ATROPHY; ESTROGEN THERAPY; HUMAN; LOWER URINARY TRACT SYMPTOM; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; OVERACTIVE BLADDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRESS INCONTINENCE; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC THERAPY; URINARY TRACT INFECTION; UROGENITAL ATROPHY; UROGENITAL TRACT DISEASE; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; URINARY TRACT; URINARY TRACT INFECTIONS; WOMEN'S HEALTH;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PROGESTINS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; URINARY TRACT; URINARY TRACT INFECTIONS; WOMEN'S HEALTH;

EID: 84901394663     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1177/1754045313511398     Document Type: Article

References (71)

1. Iosif S,Batra S,Ek Aet al.Oestrogens receptors in the human female lower urinary tract.Am J Obstet Gynaecol. 1981;141:817-820.
2. Batra SC,Iosif LS.Progesterone receptors in the female urinary tract.J Urol. 1987;138:130-134.
3. Iosif C,Bekassy Z.Prevalence of genitourinary symptoms in the late menopause.Acta Obstet Gynaecol Scan. 1984;63:257-260.
4. Green S,Walter P,Kumar Vet al.Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.Nature. 1986;320:134-139.
5. Kuiper G,Enmark E,Pelto-Huikko Met al.Cloning of a novel oestrogen receptor expressed in rat prostate and ovary.Proc Natl Acad Sci USA. 1996;93:5925-5930.
6. Warner M,Nilsson S,Gustafsson JA.The oestrogen receptor family.Curr Opin Obstet Gynecol. 1999;11:249-254.
7. Blakeman PJ,Hilton P,Bulmer JN.Mapping oestrogen and progesterone receptors throughout the female lower urinary tract.Neurourol Urodyn. 1996;15:324-325.
8. Ingelman-Sundberg A,Rosen J,Gustafsson SA.Cytosol oestrogen receptors in urogenital tissues in stress incontinent women.Acta Obstet Gynecol Scand. 1981;60:585-586.
9. Bernstein IT.The pelvic floor muscles: muscle thickness in healthy and urinary-incontinent women measured by perineal ultasonography with reference to the effect of pelvic floor training. Oestrogen receptor studies.Neurourol Urodyn. 1997;16:237-275.
10. Chen GD,Oliver RH,Leung BSet al.Oestrogen receptor α and β expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women.Fertil Steril. 1999;71:1099-1102.
11. Screiter F,Fuchs P,Stockamp K.Oestrogenic sensitivity of α receptors in the urethral musculature.Urol Int. 1976;31:13-19.
12. Blakeman PJ,Hilton P,Bulmer JN.Androgen receptors in the female lower urinary tract.Int Urogynaecol J. 1997;8:S54-S54.
13. Blakeman PJ,Hilton P,Bulmer JN.Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status.BJU Int. 2000;86:32-38.
14. Rud T,Anderson KE,Asmussen Met al.Factors maintaining the urethral pressure in women.Invest Urol. 1980;17:343-347.
15. Malone-Lee JManaging and measuring incontinence: Proceedings of the geriatric workshop on incontinence. Brocklehurst JC, ed. 1988:.
16. Versi E,Cardozo LDThe menopause. Studd JWW and Whitehead MI, ed. Oxford: Blackwell Scientific Publications; 1988:76-84.
17. Kinn AC,Lindskog M.Oestrogens and phenylpropanolamine in combination for stress incontinence.Urology. 1988;32:273-280.
18. Smith PJBThe management of the menopause and postmenopausal years. Campbell S, ed. Carnforth: MTP; 1976:291-298.
19. Samsioe G,Jansson I,Mellstrom Det al.Occurrence, nature and treatment of urinary incontinence in a 70 year old female population.Maturitas. 1985;7:335-342.
20. Hextall A,Bidmead J,Cardozo Let al.Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation.Neurourol Urodyn. 1999;18:282-283.
21. Van Geelen JM,Doesburg WH,Thomas CMG.Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile.Am J Obstet Gynaecol. 1981;141:384-392.
22. Burton G,Cardozo LD,Abdalla Het al.The hormonal effects on the lower urinary tract in 282 women with premature ovarian failiure.Neurourol Urodyn. 1992;10:318-319.
23. Cutner A,Burton G,Cardozo LDet al.Does progesterone cause an irritable bladder?.Int Urogynaecol J. 1993;4:259-261.
24. Benness C,Gangar K,Cardozo LDet al.Do progestogens exacerbate urinary incontinence in women on HRT?.Neurourol Urodyn. 1991;10:316-318.
25. Elliot RA,Castleden CM.Effect of progestogens and oestrogens on the contractile response of rat detrusor muscle to electrical field stimulation.Clin Sci. 1994;87:342-342.
26. Cutner A. The urinary tract in pregnancy. MD Thesis, University of London, 1993.
27. Sandford JP.Urinary tract symptoms and infection.Ann Rev Med. 1975;26:485-505.
28. Boscia JA,Kaye D.Asymptomatic bacteria in the elderly.Infect Dis Clin North Am. 1987;1:893-903.
29. Iosif CS.Effects of protracted administration of oestriol on the lower genitourinary tract in postmenopausal women.Acta Obstet Gynaecol Scand. 1992;251:115-120.
30. American National Institute of Health Population figures. US Treasury Department, NIH; 1991:.
31. WHO. Research on the menopause in the 1990s. Report or a WHO Scientific Group. WHO Technical Report Series 866. Geneva, Switzerland: WHO, 1994.
32. Greendale GA,Judd JL.The menopause: health implications and clinical management.J Am Geriatr Soc. 1993;41:426-436.
33. Van Geelen JM,Van de Weijer PH,Arnolds HT.Urogenital symptoms and resulting discomfort in non-institutionalised Dutch women aged 50-75 years.Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:9-14.
34. Versi E,Harvey MA,Cardozo Let al.Urogenital prolapse and atrophy at menopause: a prevalence study.Int Urogynaecol J Pelvic Dysfunct. 2001;12:107-110.
35. Davila GW,Karapanagiotou I,Woodhouse Set al.Are women with urogenital atrophy symptomatic?.Obstet Gynaecol. 2001;97:S48-S48.
36. Grady D,Brown JS,Vittinghoff Eet al.Postmenopausal hormones and incontinence: the Heart and Estrogen/progestin Replacement Study.Obstet Gynaecol. 2001;97:116-120.
37. Grodstein F,Lifford K,Resnick NMet al.Postmenopausal hormone therapy and risk of developing urinary incontinence.Obstet Gynaecol. 2004;103:254-260.
38. Hendrix SL,Cochrane BR,Nygaard IEet al.Effects of estrogen with and without progestin on urinary incontinence.JAMA. 2005;293:935-948.
39. Keane DP,Sims TJ,Abrams Pet al.Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence.Br J Obstet Gynaecol. 1997;104:994-998.
40. Falconer C,Blomgren B,Johansson Oet al.Different organisation of collagen fibrils in stress incontinent women of fertile age.Acta Obstet Gynaecol Scand. 1998;77:87-94.
41. Edwall L,Carlstrom K,Jonasson AF.Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence.Neurourol Urodyn. 2007;26:410-415.
42. Jackson S,James M,Abrams P.The effect of oestradiol on vaginal collagen metabolism in post menopausal women with genuine stress incontinence.Br J Obstet Gynaecol. 2002;109:339-344.
43. Aikawa K,Sugino T,Matsumoto Set al.The effect of ovariectomy and oestradiol on rabbit bladder smooth muscle contraction and morphology.J Urol. 2003;170 (2 pt 1): 634-637.
44. Caine M and Raz S. The role of female hormones in stress incontinence. In: Proceedings of the 16 congress of the international society of urology, 1973, Amsterdam, The Netherlands.
45. Rud T.The effects of oestrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women.Acta Obstet Gynaecol Scand. 1980;59:265-270.
46. Wilson PD,Faragher B,Butler Bet al.Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.Br J Obstet Gynaecol. 1987;94:568-574.
47. Walter S,Wolf H,Barlebo Het al.Urinary incontinence in postmenopausal women treated with oestrogens: a double-blind clinical trial.J Urol. 1978;33:135-143.
48. Fantl JA,Bump RC,Robinson Det al.Efficacy of oestrogen supplementation in the treatment of urinary incontinence.Obstet Gynaecol. 1996;88:745-749.
49. Jackson S,Shepherd A,Brookes Set al.The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind, placebo controlled trial.Br J Obstet Gynaecol. 1999;106:711-718.
50. Sultana CJ,Walters MD.Oestrogen and urinary incontinence in women.Maturitas. 1995;20:129-138.
51. Hong SK,Yang JH,Kim TBet al.Effects of ovariectomy and oestrogen replacement on the function and expression of Rho-kinase in rat bladder smooth muscle.BJU Int. 2006;98:1114-1117.
52. Yoshida J,Aikawa K,Yoshimura Yet al.The effects of ovariectomy and oestrogen replacement on acetylcholine release from nerve fibres and passive stretch induced acetylcholine release in female rats.Neurourol Urodyn. 2007;26:1050-1055.
53. Samsicoe G,Jansson I,Mellstrom Det al.Urinary incontinence in 75 year old women. Effects of oestriol.Acta Obstet Gynaecol Scand. 1985;93:57-57.
54. Cardozo LD,Rekers H,Tapp Aet al.Oestriol in the treatment of postmenopausal urgency: a multicentre study.Maturitas. 1993;18:47-53.
55. Benness C,Wise BG,Cutner Aet al.Does low dose vaginal oestradiol improve frequency and urgency in postmenopausal women.Int Urogynaecol J. 1992;3:281-281.
56. Eriksen PS,Rasmussen H.Low dose 17β-oestradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.Eur J Obstet Gynaecol Reprod Biol. 1992;44:137-144.
57. Cardozo L,Lose G,McClish Det al.Estrogen treatment for symptoms of an overactive bladder, results of a meta analysis.Int J Urogynaecol. 2001;12:V-V.
58. Tseng LH,Wang AC,Chang YLet al.Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.Neurourol Urodyn. 2009;28:47-51.
59. Serati M,Salvatore S,Uccella Set al.Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?.Eur Urol. 2009;55:713-719.
60. Nelken RS,Ozel BZ,Leegant ARet al.Randomised trial of oestradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder.Menopause. 2011;18:962-966.
61. Brandberg A,Mellstrom D,Samsioe G.Low dose oral oestriol treatment in elderly women with urogenital infections.Acta Obstet Gynaecol Scand. 1987;140:33-38.
62. Parsons CL,Schmidt JD.Control of recurrent urinary tract infections in postmenopausal women.J Urol. 1982;128:1224-1226.
63. Privette M,Cade R,Peterson Jet al.Prevention of recurrent urinary tract infections in postmenopausal women.Nephron. 1988;50:24-27.
64. Raz R,Stamm WE.A controlled trial of intravaginal oestriol in postmenopausal women with recurrent urinary tract infections.N Engl J Med. 1993;329:802-803.
65. Kirkengen AL,Anderson P,Gjersoe Eet al.Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.Scan J Prim Health Care. 1992;10:142-142.
66. Cardozo LD,Benness C,Abbott D.Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.Br J Obstet Gynaecol. 1998;105:403-407.
67. Cardozo L,Lose G,McClish Det al.A systematic review of oestrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee.Int Urogynaecol J. 2001;12:15-20.
68. Cardozo LD,Bachmann G,McClish Det al.Meta-analysis of oestrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee.Obstet Gynaecol. 1998;92:722-727.
69. Cody JD,Richardson K,Moehrer Bet al.Oestrogen therapy for urinary incontinence in post-menopausal women.Cochrane Database Syst Rev. 2009;4:CD001405-CD001405.
70. Moehrer B,Hextall A,Jackson S.Oestrogens for urinary incontinence in women.Cochrane Database Syst Rev. 2003;2:CD001405-CD001405.
71. Suckling J,Lethaby A,Kennedy R.Local oestrogen for vaginal atrophy in postmenopausal women.Cochrane Database Syst Rev. 2003;4:CD001500-CD001500.